Arix Bioscience is an institutional investor (Healthcare Startups) founded in 2016 and headquartered in London, United Kingdom. Venture capital fund investing in biotech startups. Venture capital company focused on investing in and building biotech companies around the life sciences sector. As an institutional investor, the firm manages capital on behalf of institutional limited partners, deploying capital across selected investment opportunities with strong growth potential.

Stage

seed, Series A, Series B, growth capital, preclinical, clinical, late-stage, seed, Series A, Series B, growth capital, preclinical, clinical, late-stage

Check size

$10M-$50M

HQ

London, United Kingdom

Founded

2016

Website

https://arixbioscience.com

LinkedIn

https://linkedin.com/company/arix-bioscience-plc

Twitter

http://twitter.com/arixbioscience

What they look for

global geography; breakthrough science in life sciences; strong entrepreneurial teams; clinical/preclinical progress; prefers board seats [Investing.com], [Hopohopo]

Preparing to pitch Arix Bioscience?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.